当前位置:首页 - 行情中心 - 立方制药(003020) - 财务分析 - 现金流量表

立方制药

(003020)

  

流通市值:45.61亿  总市值:62.99亿
流通股本:1.38亿   总股本:1.90亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金886,897,488.23406,963,122.741,548,621,716.571,172,507,799.62
  收到的税费返还20,726113,292.461,151,676.52,621,310.22
  收到其他与经营活动有关的现金33,806,088.6123,614,457.1844,481,206.3225,486,152.87
  经营活动现金流入小计920,724,302.84430,690,872.381,594,254,599.391,200,615,262.71
  购买商品、接受劳务支付的现金320,484,856.11139,979,682.17369,357,669.69279,971,868.4
  支付给职工以及为职工支付的现金111,763,195.665,853,534.83190,909,549.74142,049,881.97
  支付的各项税费88,496,714.3639,645,112.84172,960,048.76140,731,040.56
  支付其他与经营活动有关的现金303,377,068.78149,151,329.23663,494,588.43511,185,709.12
  经营活动现金流出小计824,121,834.85394,629,659.071,396,721,856.621,073,938,500.05
  经营活动产生的现金流量净额96,602,467.9936,061,213.31197,532,742.77126,676,762.66
二、投资活动产生的现金流量:
  收回投资收到的现金218,377,416.0155,000,000375,000,000275,000,118.72
  取得投资收益收到的现金22,171,581.682,917,754.725,891,942.856,031,913.84
  处置固定资产、无形资产和其他长期资产收回的现金净额75,213.142,000492,272.829,105.19
  投资活动现金流入小计240,624,210.8357,919,754.72381,384,215.65281,061,137.75
  购建固定资产、无形资产和其他长期资产支付的现金65,219,814.8835,088,231.6154,486,796.04108,141,182.31
  投资支付的现金331,860,00041,860,000384,652,054.79383,412,054.79
  取得子公司及其他营业单位支付的现金--24,480,00024,480,000
  投资活动现金流出小计397,079,814.8876,948,231.6563,618,850.83516,033,237.1
  投资活动产生的现金流量净额-156,455,604.05-19,028,476.88-182,234,635.18-234,972,099.35
三、筹资活动产生的现金流量:
  吸收投资收到的现金--100,000-
  其中:子公司吸收少数股东投资收到的现金--100,000-
  取得借款收到的现金--28,600,00028,600,000
  收到其他与筹资活动有关的现金86,4951,0001,115,754.3517,727.92
  筹资活动现金流入小计86,4951,00029,815,754.329,117,727.92
  分配股利、利润或偿付利息支付的现金117,509,325.9238,252,10096,613,353.2796,370,631.83
  其中:子公司支付给少数股东的股利、利润--15,680,000-
  支付其他与筹资活动有关的现金11,753,465.164,187,617.411,534,146.737,382,039.23
  筹资活动现金流出小计129,262,791.0842,439,717.4108,147,500103,752,671.06
  筹资活动产生的现金流量净额-129,176,296.08-42,438,717.4-78,331,745.7-74,634,943.14
四、汇率变动对现金及现金等价物的影响-7,247-1,133.255,484.88-8,840.68
五、现金及现金等价物净增加额-189,036,679.14-25,407,114.22-63,028,153.23-182,939,120.51
  加:期初现金及现金等价物余额439,694,059.59436,891,607.84502,722,212.82502,722,212.82
  期末现金及现金等价物余额250,657,380.45411,484,493.62439,694,059.59319,783,092.31
补充资料:
  净利润91,530,260.09-152,480,813.62-
  资产减值准备9,495,304.44-15,872,377.92-
  固定资产和投资性房地产折旧36,557,769.15-66,094,431.36-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧36,557,769.15-66,094,431.36-
  无形资产摊销4,864,039.72-9,392,912.65-
  长期待摊费用摊销1,396,784.57-2,762,276.78-
  处置固定资产、无形资产和其他长期资产的损失-1,769.91--20,097.78-
  固定资产报废损失1,372.76-4,719,722.95-
  公允价值变动损失-141,882.36--1,601,131.58-
  财务费用1,408,492.45-1,914,963.84-
  投资损失-26,123,630.38--11,401,826.54-
  递延所得税-1,472,539.33--2,881,741.93-
  其中:递延所得税资产减少-670,210.24-1,621,383.39-
    递延所得税负债增加-802,329.09--4,503,125.32-
  存货的减少-46,901,989.09-13,553,921.55-
  经营性应收项目的减少10,044,178.23--133,755,118.31-
  经营性应付项目的增加11,739,322.91-68,916,946.76-
  其他482,954.53-3,239,430.09-
  融资租入固定资产--10,399,309.93-
  现金的期末余额250,657,380.45-439,694,059.59-
  减:现金的期初余额439,694,059.59-502,722,212.82-
  现金及现金等价物的净增加额-189,036,679.14--63,028,153.23-
公告日期2025-08-262025-04-222025-04-222024-10-30
审计意见(境内)标准无保留意见
TOP↑